DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Dilaudid (Hydromorphone Hydrochloride) - Summary

 

-- advertisement --

DILAUDID SUMMARY

DILAUDID® ORAL LIQUID and DILAUDID® 8 mg TABLETS
(hydromorphone hydrochloride)

DILAUDID (hydromorphone hydrochloride), a hydrogenated ketone of morphine, is an opioid analgesic.

DILAUDID is indicated for the relief of moderate to severe pain such as that due to:

Surgery

Cancer

Trauma (soft tissue & bone)

Biliary Colic

Myocardial Infarction

Burns

Renal Colic

DILAUDID NEWS HIGHLIGHTS

Published Studies Related to Dilaudid (Hydromorphone)

Relief of incident dyspnea in palliative cancer patients: a pilot, randomized, controlled trial comparing nebulized hydromorphone, systemic hydromorphone, and nebulized saline. [2008.07]

Relief of Incident Dyspnea in Palliative Cancer Patients: A Pilot, Randomized, Controlled Trial Comparing Nebulized Hydromorphone, Systemic Hydromorphone, and Nebulized Saline. [2008.03.19]

Conversion from standard opioid therapy to once-daily oral extended-release hydromorphone in patients with chronic cancer pain. [2008.03]

Pharmacokinetic profile of a 24-hour controlled-release OROS formulation of hydromorphone in the presence of alcohol. [2008.01]

Metoclopramide versus hydromorphone for the emergency department treatment of migraine headache. [2008.01]

more>>

Clinical Trials Related to Dilaudid (Hydromorphone)

Study of the Effectiveness and Tolerability of OROS Hydromorphone HCI SR(Slow-Release) Tablets and Immediate-Release Hydromorphone Tablets in Patients With Chronic Pain [Completed]

An Open-Label Evaluation of the Independent Effects of Coadministration of a High-Fat Meal and Naltrexone Blockade on the Pharmacokinetic Profile of Dilaudid OROS (Hydromorphone HCI) 16mg [Completed]

A Study on Efficacy (Effectiveness), Safety, and Impact on Quality of Life Measures of Dilaudid CR (Controlled Release);, Hydromorphone HCl in Patients With Chronic Low Back Pain [Completed]

Comparison of Side Effects of Morphine and Hydromorphone PCA [Completed]

Safety Study of Intravenous Hydromorphone Using Incremental 1mg Doses up to 2mg for Adult ED Patients [Active, not recruiting]

more>>

Page last updated: 2008-08-10

-- advertisement -- The American Red Cross

We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2008